TELIX INNOVATIONS
ActiveTELIX INNOVATIONS has been active since 2015 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €116.66M and a net result of €62.40M. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 25% of 64 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).
Checked score
Score 2025
76
/ 100
Excellent▼ -8 vs 2024
The score combines four axes. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency43▲+18
Growth85=
Stability100
Bankruptcy probability, 12 months
0.3%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €2M at 30 days acceptable
Liquidity tight (current ratio 1.3 against 1.18 in 2024), and 75.4% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Nine signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
24.6%
Return on assets
13.2%
Age of the figures
8 mo
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 21
Relative position
BE, all sectors
reference
Sector 21
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 25% of 64 sector peers (2025).
NBB · sector comparisonPosition among 64 sector peers
Solvency
better than 25%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-07-2026, 0 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
on the day
2024
on the day
2023
141 d late
2022
126 d late
2021
23 d early
2020
31 d late
2019
61 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
14-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, full schema
Turnover
€243.78M▼ 23.8%
2024 · €320.05M
2018: €1.53M
2019: €2.25M
2020: €4.88M
2024: €320.05M
2018 → 2025
EBIT margin
43.6%▼ 22.7pp
2024 · 66.3%
2018: -9.6%
2019: -52.8%
2020: 18.9%
2024: 66.3%
2018 → 2025
Net result
€62.40M▼ 67.8%
2024 · €194.03M
2018: €-169k
2019: €-1.17M
2020: €241k
2021: €86k
2022: €21.46M
2024: €194.03M
2018 → 2025
Working capital
€107.10M▲ 102%
2024 · €52.93M
2018: €-320k
2019: €-647k
2020: €613k
2021: €22.46M
2022: €22.71M
2024: €52.93M
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20202021202220242025Trend
Turnover€4.88M-€320.05M€243.78M▼ 23.8%
Equity€3.53M-€2.79M▼ 21.1%€24.04M▲ 762%€54.26M▲ 126%€116.66M▲ 115%
Operating result€921k-€-1.16M€22.57M€212.16M▲ 840%€106.18M▼ 50.0%
Net result€241k-€86k▼ 64.5%€21.46M▲ 24,992%€194.03M▲ 804%€62.40M▼ 67.8%
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 50% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €473.35M
Fixed assets
€11.23M▲ 497%
Current assets
€462.12M▲ 33.8%
Equity and liabilities €473.35M
Equity
€116.66M▲ 115%
Debt
€356.70M▲ 21.7%
The debt ratio falls from 84.4% to 75.4%: equity grows faster than debt.
Key figures and ratios
EBITDA
€184.60M▼
2024 · €222.00M
Cash flow
€140.83M▼
2024 · €203.88M
Solvency
24.6%▲
2024 · 15.6%
Current ratio
1.30▲
2024 · 1.18
Quick ratio
1.27▲
2024 · 1.13
Debt / equity
3.06▼
2024 · 5.40
ROE
53.5%▼
2024 · 357.6%
ROA
13.2%▼
2024 · 55.9%
Interest coverage
4962.06▼
2024 · 6946.88
Debt
€356.70M▲
2024 · €293.10M
Debt ≤ 1 year
€355.02M▲
2024 · €292.55M
Debt > 1 year
€1.33M▲
2024 · €210k
Income taxes
€133k▼
2024 · €36.81M
Staff costs
€6.26M▲
2024 · €2.94M
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€347.36M€473.35M▲
Formation expenses20€194€0▼
Fixed assets21/28€1.88M€11.23M▲
Intangible fixed assets21€1.52M€11.04M▲
Tangible fixed assets22/27€360k€187k▼
Plant, machinery and equipment23€84k€50k▼
Furniture and vehicles24€29k€13k▼
Leasing and similar rights25€87k€74k▼
Other tangible fixed assets26€60k€51k▼
Assets under construction and advance payments27€100k€0▼
Financial fixed assets28€5k€5k▼
Other financial fixed assets284/8€5k€5k▼
Amounts receivable and cash guarantees285/8€5k€5k▼
Current assets29/58€345.48M€462.12M▲
Amounts receivable after more than one year29€88.33M€394.23M▲
Other amounts receivable291€88.33M€394.23M▲
Stocks and contracts in progress3€13.98M€12.55M▼
Stocks30/36€13.98M€12.55M▼
Raw materials and consumables30/31€6.40M€7.07M▲
Work in progress32€5.05M€4.68M▼
Finished goods33€2.53M€793k▼
Amounts receivable within one year40/41€216.13M€37.53M▼
Trade receivables40€173.04M€33.88M▼
Other amounts receivable41€43.10M€3.65M▼
Cash at bank and in hand54/58€26.93M€17.62M▼
Deferred charges and accrued income490/1€111k€188k▲
Equity and liabilities
Total equity and liabilities10/49€347.36M€473.35M▲
Equity10/15€54.26M€116.66M▲
Contributions10/11€4.12M€4.12M=
Capital10€4.12M€4.12M=
Issued capital100€4.12M€4.12M=
Reserves13€412k€412k=
Non-distributable reserves130/1€412k€412k=
Legal reserve130€412k€412k=
Profit (loss) carried forward14€49.65M€112.05M▲
Investment grants15€78k€78k=
Amounts payable17/49€293.10M€356.70M▲
Amounts payable after more than one year17€210k€1.33M▲
Other amounts payable178/9€210k€1.33M▲
Amounts payable within one year42/48€292.55M€355.02M▲
Current portion of amounts payable after more than one year42€68k€68k=
Trade debts44€88.64M€165.47M▲
Suppliers440/4€88.64M€165.47M▲
Advances received on contracts in progress46€130k€223k▲
Taxes, remuneration and social security45€53.14M€38.65M▼
Taxes450/3€52.54M€38.03M▼
Remuneration and social security454/9€596k€619k▲
Other amounts payable47/48€150.57M€150.61M=
Accrued charges and deferred income492/3€342k€345k▲
Income statement
Code20242025
Operating income70/76A€333.20M€331.85M▼
Turnover70€320.05M€243.78M▼
Change in stocks of work in progress, finished goods and contracts in progress71€2.45M€-2.46M▼
Own construction capitalised72€8.73M€77.82M▲
Other operating income74€1.97M€12.72M▲
Non-recurring operating income76A€0-
Operating charges60/66A€121.05M€225.68M▲
Goods for resale, raw materials and consumables60€23.00M€12.13M▼
Purchases600/8€24.86M€12.80M▼
Change in stocks: decrease (increase)609€-1.87M€-667k▲
Services and other goods61€86.08M€129.19M▲
Remuneration, social security and pensions62€2.94M€6.26M▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€9.85M€78.43M▲
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4€-842k€-365k▲
Other operating charges640/8€29k€27k▼
Non-recurring operating charges66A€0€3k▲
Operating profit (loss)9901€212.16M€106.18M▼
Financial income75/76B€21.10M€11.65M▼
Recurring financial income75€21.10M€11.65M▼
Income from financial fixed assets750€0-
Income from current assets751-€5.45M
Other financial income752/9€21.10M€6.20M▼
Financial charges65/66B€2.41M€55.29M▲
Recurring financial charges65€2.41M€55.29M▲
Debt charges650€32k€37k▲
Other financial charges652/9€2.38M€55.26M▲
Profit (loss) for the period before taxes9903€230.85M€62.53M▼
Income taxes67/77€36.81M€133k▼
Taxes670/3€36.81M€579k▼
Tax adjustments and reversals of tax provisions77-€445k
Profit (loss) for the period9904€194.03M€62.40M▼
Profit (loss) for the period to be appropriated9905€194.03M€62.40M▼
Appropriation of the result
Profit (loss) to be appropriated9906€279.95M€112.05M▼
Profit (loss) brought forward from the previous period14P€85.91M€49.65M▼
Transfer to equity691/2€0-
To the legal reserve6920€0-
Profit to be distributed694/7€230.30M€0▼
Return on contributions (dividend)694€230.30M€0▼
Social balance
Average headcount (FTE)908716.319.8▲
The notes to these accounts (81 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
31-07
NBB filing
Annual accounts filed
fiscal year 2025 · full schema
2025
31-12
Financial
Equity above €100MEq €116.66M ▲115%
5 profitable years in a row build equity to €116.66M.
31-07
NBB filing
Annual accounts filed
fiscal year 2024 · full schema
2024
31-12
Financial
Highest result since 2018net €194.03M ▲804%
Operating result €212.16M, net result €194.03M, both a record.
31-12
Financial
Equity above €50MEq €54.26M ▲126%
4 profitable years in a row build equity to €54.26M.
19-12
NBB filing
Annual accounts filed
fiscal year 2023 · full schema · 141 days late
2023
04-12
NBB filing
Annual accounts filed
fiscal year 2022 · full schema · 126 days late
2022
31-12
Financial
Equity above €10MEq €24.04M ▲762%
3 profitable years in a row build equity to €24.04M.
08-07
NBB filing
Annual accounts filed
fiscal year 2021 · full schema
2021
31-12
Financial
Liquidity times 9current ratio 8.87
Current ratio from 1.03 to 8.87; short-term debt falls from €21.95M to €2.85M.
31-08
NBB filing
Annual accounts filed
fiscal year 2020 · full schema · 31 days late
2020
31-12
Financial
Back to profitnet €241k
Net result €241k after 2 loss-making years.
31-12
Financial
Equity above €2MEq €3.53M
Equity rises from €-210k to €3.53M.
30-09
NBB filing
Annual accounts filed
fiscal year 2019 · full schema · 61 days late
2019
31-12
Financial
Weakest financial yearnet €-1.17M
Net result drops to €-1.17M, the lowest in the series; recovery starts the following year.
21-06
NBB filing
Annual accounts filed
fiscal year 2018 · full schema
2018
23-07
NBB filing
Annual accounts filed
fiscal year 2017 · full schema
2017
25-07
NBB filing
Annual accounts filed
fiscal year 2016 · full schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
no sitting director, no change since 2023
We have established no sitting directors for this company. We derive directors from published Gazette acts; while there are none, or none read, nothing appears here. That does not mean the company has none: the CBE keeps its own list of function holders, which we do not read.
15-08-2023
Melanie FARRIS: Resigned as Director
15-08-2023
Richard VALEIX: Resigned as Director
31-07-2022
Douglas Cubbin: Resigned as Director
01-11-2021
Christian Behrenbruch: Resigned as Director
23-08-2021
Bringing Mind 2 Business: Resigned as Director
23-08-2021
VOCCIA Samuel: Resigned as Managing director
23-08-2021
WOUTERS Ludovic: Resigned as Managing director
17-01-2019
WOUTERS Ludovic: Resigned as Director
17-01-2019
ILUSA: Resigned as Director
17-01-2019
NOSHAQ PARTNERS: Resigned as Director
17-01-2019
ZIMMERMANN Richard: Resigned as Director
Location & real-estate footprint
Registered office, Herstal · 1 establishment unit since 2015
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Rue de Hermée 2554040 HerstalGround area
3,113 m²
Parcel 62312A0308/00D000, Wallonia. Linked by address, not a title deed.
1 establishment unit
ADVANCED NUCLEAR MEDICINE INGREDIENTS
since 20152.241.740.373
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 62312A0308/00D000 | Wallonia | 3,113 m² | - | - |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Structure & network
Connections & network
4 connected companiesNetwork connections
Shared address
→
Shared address
→
Shared address
→
Shared address
→
Similar companies · same sector, comparable size
JNTL Consumer Health (Belgium)
BE 0782.678.251
Antwerpen · Eq €133.44M
PolyPeptide
BE 0879.346.768
Braine-l'Alleud · Eq €96.61M
Catalent Gosselies
BE 0840.843.708
Charleroi · Eq €53.74M
AJINOMOTO OMNICHEM
BE 0403.078.352
Wetteren · Eq €323.88M
MECS EUROPE/AFRICA
BE 0875.005.128
Hoeilaart · Eq €36.53M
Of 150 companies in sector 21100 we hold annual accounts for 108. 10 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPublic limited company
Founded27-03-2015
Fiscal year end31-12
Abbreviation FR
ANMI
Activities, NACEBEL
21100Manufacture of basic pharmaceutical products and pharmaceutical preparations
72101Research and development on biotechnology
Sources
Crossroads Bank for EnterprisesNational Bank · 10 filingsAddress and cadastre registers
Data from official sources, last processed on 14-09-2026. Scores and ratios are computed by Checked and are not a credit decision.